Topical Interleukin 1 Receptor Antagonist for Treatment of Dry Eye Disease: A Randomized Clinical Trial

IMPORTANCE: The immunopathogenic mechanisms of dry eye disease (DED), one of the most common ophthalmic conditions, is incompletely understood. Data from this prospective, double-masked, randomized trial demonstrate that targeting interleukin 1 (IL-1) by topical application of an IL-1 antagonist is...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Amparo, Francisco, Dastjerdi, Mohammad H., Okanobo, Andre, Ferrari, Giulio, Smaga, Leila, Hamrah, Pedram, Jurkunas, Ula, Schaumberg, Debra A., Dana, Reza
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4167802/
https://ncbi.nlm.nih.gov/pubmed/23599118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2013.195
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi